The pharmaceutical lipids market is anticipated to expand its roots at an average CAGR of 5.0% during the forecast period. The market is likely to hold a revenue of USD 4.93 billion in 2023 while it is anticipated to cross a value of USD 8.04 billion by 2033.
The expanding pharmaceutical industry involving the usage of lipids as an energy regulator is flourishing the market growth. Furthermore, the lips work as pillar excipients for enhanced fabrication of various dosage forms across the drug framework. The high demand for lipophilic, insoluble drugs along with the poor bioavailability is pushing pharmaceutical brands to adopt lipid-based dosage forms.
The pharmaceutical importance of oils and fats is also adding value to lipid functions. The elements lipid offers for pharmaceutical applications include fatty acids, glycerol, steroids, other alcohols, and fatty aldehydes. The application of lipids in pharmaceutical and cosmetic preparations is also garnering the demand for pharmaceutical lipids. The cosmetic application includes binders, lubricants, emulsifiers, ointments, creams, and lotions.
The growing awareness around the lipid's benefits and its utmost usage in drug formation is flourishing the demand for pharmaceutical lipids. Alongside this, the rancidity and hydrolytic decomposition properties also help in the production of glycerol and fatty acids.
Increasing adoption of a wide range of natural, synthetic, semi-synthetic, or completely man-made lipids and polymers in the formulation of various dosage forms is expected to boost the market over the forecast period. Apart from the pharmaceutical importance of lipids, the agricultural application of these lipids works as biological membranes for soil enhancement.
| Attributes | Details |
|---|---|
| Pharmaceutical Lipids Market CAGR (2023 to 2033) | 5.0% |
| Pharmaceutical Lipids Market Size (2023) | USD 4.93 billion |
| Pharmaceutical Lipids Market Size (2033) | USD 8.04 billion |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
Short-term Growth (2023 to 2026): The lipids as in fixed oils, fats, and waxes work as esters of long-chain fatty acids and alcohols. The driving pharmaceutical industry along with its delivery provides energy reserves for drug creation and helps the market growth. With these wide ranges of applications, the market is expected to hold USD 4.93 billion in 2023 while it is anticipated to reach USD 5.71 billion by 2026.
Mid-term Growth (2026 to 2029): The expansion of the pharmacognosy branch of the pharmaceutical industry is flourishing with the demand for pharmaceutical lipids. Also, diverse drugs containing lipids are getting popular in the market space. This takes a market value from USD 5.71 billion in 2026 to a value of USD 6.61 billion in 2029.
Long-term Growth (2029 to 2033): The application of lipids as a component of biological membranes while it delivers energy reserves in the form of triacylglycerols. Furthermore, lipids are also being used as vitamins and hormone delivery. The market is anticipated to thrive at a slightly low CAGR of 5.0% between 2023 and 2033.
The FDA and other regulatory agencies are focusing on the controlled usage of lipids while it is helping the pharmaceutical industries bloom. The penetration of lipids in the pharmaceutical industry for outsourcing procedures is transforming market conditions. Furthermore, advanced lipid products come with good flexibility that covers several pharmaceutical operations.
Rising demand in emerging economies is pushing local drug production, which is fueling sales in the market. Manufacturers are investing in research and development to formulate specific products to tap into this market. There are collaborations and mergers between companies for market expansion and distribution channel growth. The extended research and development facilities are also contributing to the deployment of lipid products.
Principal Consultant
Some of the key restraints for the pharmaceutical lipids market are a high number of approvals and regulatory certificates limiting the demand for pharmaceutical lipids. Furthermore, the drug development process includes registration, licensing, marketing, and manufacturing procedures. These procedures are restricting the market growth.
The expansion of the pharmaceutical industry across the globe is resulting in an increasing number of regulations to control the quality and efficacy of drugs. Regulatory agencies and organizations play a vital role in meeting the requirements of legal procedures related to the drug development process in a country.
| Region/Country | Revenue Share % (2022) |
|---|---|
| The United States | 26.1% |
| Germany | 8.8% |
| Japan | 6.4% |
| North America | 27.6% |
| Europe | 27.15% |
Expansion of the Healthcare Sector in the United States is Fueling Sales of Pharmaceutical Lipids
The United States pharmaceutical lipids market leads in terms of market share in North American region. The region is expected to hold a market share of 26.1% in 2023. North America market held a share of 27.6% in 2022 due to the expanding pharmaceutical industry, and research and development facilities.
The new product launches and collaborations are gaining traction in the market. The presence of key players in the country is anticipated to bode well for the market. For example, Merck introduced their extending strategic partnership with BioNTech to expand the supply of urgently needed lipids while proliferating the quantities to be delivered in the forecast period.
Growing Investments in the Healthcare Sector might Fuel the Applications of Lipids in India Pharmaceutical Industry
India pharmaceutical lipids market thrives at a CAGR of 5.0% between 2023 and 2033. The growth is attributed to the booming pharmaceutical sector with leading production of drugs across the world.
Researchers in India are focusing on nanotechnology to deliver lipid nanoparticles used in the treatment of various diseases such as cancer, skin disorders, etc. Lipid nanoparticles include liposomes, nanoemulsions, solid lipid nanoparticles, nanostructured lipidic carriers, and supramolecular carriers.
Increasing Drug Development, and Expanding Pharmaceutical Sector in the United Kingdom is Bolstering Applications of Lipids
The United Kingdom market thrives at a CAGR of 4.70% during the forecast period. The growth is attributed to the pharmaceutical and cosmetics market. Though Europe region held a market share of 27.15% in 2022, the growth is attributed to the high demand for lipid-based drugs and expanding pharmaceutical sector.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Category | By Products |
|---|---|
| Leading Segment | Triglycerides |
| Market Share (2022) | 45.3% |
| Category | By Source |
|---|---|
| Leading Segment | Semi-synthetic |
| Market Share (2022) | 48.1% |
Based on product type, triglycerides lead as it held a significant market share of 45.3% in 2022. The growth of this segment is due to its consumption of various personal care products. For example,
Based on the source, the semi-synthetic segment leads as it held a market share of 48.1% in 2022. The growth of this segment has flourished through high consumption, affordable rates, and high flexibility with new pharmaceutical applications. Furthermore, the usage of lipid-based formulations is helping segmental growth.
The key players in the market adopt advanced healthcare technologies along with a better packaging program. Furthermore, strategic collaborations, acquisitions, expansion, product launches, agreements, and research sponsorship are the key strategies followed by the key players in the market.
How can Pharmaceutical Lipids Vendors Providers Scale their Businesses in the Market?
Key players in the market are working on three key strategies such as:
Market Developments:
The 2023 market value is USD 4.93 billion.
Until 2033, the market will rise at a 5.0% CAGR.
By 2033, the market will total USD 8.04 billion.
Growing demand from agricultural sector drives market expansion.
North America will be a highly lucrative market.
1. Executive Summary | Pharmaceutical Lipids Market 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Product 5.1. Triglycerides 5.2. Phospholipids 5.3. Sphingolipids 5.4. Cholesterol 5.5. Fatty Acids 5.6. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Source 6.1. Synthetic 6.2. Semi-synthetic 6.3. Natural 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Form 7.1. Liquid 7.2. Semi-solid 7.3. Solid 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 8.1. Conventional Lipid-based Drug Delivery Systems 8.2. Self-Emulsifying Drug Delivery Systems 8.3. Self-Microemulsifying Drug Delivery Systems 8.4. Liposomes 8.5. Solid Lipid Nanoparticles 8.6. Nanostructured Lipid Carriers 8.7. Others 9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Route of Administration 9.1. Oral 9.1.1. Tablet 9.1.2. Solution 9.2. Parenteral 9.2.1. Intravenous 9.2.2. Intramuscular (Vaccines) 9.3. Topical 10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 10.1. North America 10.2. Latin America 10.3. Europe 10.4. South Asia 10.5. East Asia 10.6. Oceania 10.7. MEA 11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 16. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 17. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 18. Key Countries Market Analysis 19. Market Structure Analysis 20. Competition Analysis 20.1. ABITEC Corporation 20.2. BASF SE 20.3. Croda International Plc 20.4. CordenPharma 20.5. NOF (Nippon Oil & Fats) Corporation 20.6. Cayman Chemical Company 20.7. Lipoid GmbH 20.8. Nippon Fine Chemical Co. Ltd. 20.9. Dishman Group 20.10. Gattefossé 20.11. IOI Oleo GmbH 20.12. Stepan Company 20.13. Evonik Industries AG 21. Assumptions & Acronyms Used 22. Research Methodology
Healthcare
June 2023
REP-GB-13025
273 pages
Explore Healthcare Insights
View Reports
Pharmaceutical Lipids Market
